What is Kevin Borst's NPI number?

Kevin Borst's National Provider Identifier (NPI) is 1982818506, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Kevin Borst's specialty?

Kevin Borst is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).

Where is Kevin Borst located?

Kevin Borst's practice location on file with NPPES is 14601 Detroit Ave Ste 540, Lakewood, OH 44107-4251.

What is Kevin Borst's phone number?

The practice phone number listed in the NPPES registry for Kevin Borst is (216) 529-5300.

Does Kevin Borst accept Medicare?

Kevin Borst is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Kevin Borst's NPI active?

Yes — Kevin Borst's NPI (1982818506) is active in the NPPES registry as of the last update on 2011-06-28.

IndividualActiveAccepts Medicare

Kevin Borst, DO

NPI 1982818506 · Endocrinology, Diabetes & Metabolism Physician · Lakewood, OH

Kevin Borst, DO is a Endocrinology, Diabetes & Metabolism Physician provider in Lakewood, OH (NPI 1982818506).

Provider details

NPI number: 1982818506
Entity type: Individual
Primary specialty: Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
Credential: DO
Sex: Male
Sole proprietor: No
License: 34009832 (OH)

Practice location

14601 Detroit Ave Ste 540

Lakewood, OH 44107-4251

Phone: (216) 529-5300

Street-level locationGet directions

More OH providers

Mailing address

4810 Tillman Ave

Cleveland, OH 44102-2266

Specialties & taxonomies

Endocrinology, Diabetes & Metabolism PhysicianPrimary207RE0101XLicense 34009832 (OH)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(71/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
253 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	161	$95
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	64	$32
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	17	$16
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	11	$112

Typical Medicare-allowed amounts for these services range $16–$112 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 46 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	230	61
Empagliflozinbrand: Jardiance	114	23
Metformin Hcl	112	33
Levothyroxine Sodiumbrand: Synthroid	108	23
Metformin Hclbrand: Metformin Hcl Er	102	27
Glimepiride	78	21

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$499 across 17 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-05-10
Last updated: 2011-06-28

Frequently asked questions

What is Kevin Borst's NPI number?: Kevin Borst's National Provider Identifier (NPI) is 1982818506, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Kevin Borst's specialty?: Kevin Borst is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
Where is Kevin Borst located?: Kevin Borst's practice location on file with NPPES is 14601 Detroit Ave Ste 540, Lakewood, OH 44107-4251.
What is Kevin Borst's phone number?: The practice phone number listed in the NPPES registry for Kevin Borst is (216) 529-5300.
Does Kevin Borst accept Medicare?: Kevin Borst is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Kevin Borst's NPI active?: Yes — Kevin Borst's NPI (1982818506) is active in the NPPES registry as of the last update on 2011-06-28.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	161	$95
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	64	$32
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	17	$16
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	11	$112

Drug

Part D claims (2024)

Beneficiaries

Levothyroxine Sodium

230

Empagliflozinbrand: Jardiance

114

Metformin Hcl

112

Levothyroxine Sodiumbrand: Synthroid

108

Metformin Hclbrand: Metformin Hcl Er

102

Glimepiride

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$499 across 17 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments